Latest News about Analyst Ratings
Recent news which mentions Analyst Ratings
Amgen's Rocatinlimab Has Commercial Potential Despite Competitive Landscape, Says Goldman Sachs
September 25, 2024
From Benzinga
Philip Morris Analyst Raises Forecasts Ahead Of Q3 Earnings, But 'Consumer Elasticities Remain A Risk'
September 25, 2024
Tickers
PM
From Benzinga
Visa Stock Has Near-Term 'Overhang' From DOJ Antitrust Lawsuit: Analyst Picks 3 Stocks To Benefit
September 25, 2024
From Benzinga
A Closer Look at 10 Analyst Recommendations For Celldex Therapeutics
September 25, 2024
Tickers
CLDX
From Benzinga
Encompass Health Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
September 25, 2024
Tickers
EHC
From Benzinga
Demystifying CenterPoint Energy: Insights From 12 Analyst Reviews
September 25, 2024
Tickers
CNP
From Benzinga
A Closer Look at 5 Analyst Recommendations For Repay Holdings
September 25, 2024
Tickers
RPAY
From Benzinga
The Analyst Verdict: bluebird bio In The Eyes Of 5 Experts
September 25, 2024
Tickers
BLUE
From Benzinga
Bitcoin Mining Stock's 'Strong Organic Growth' Make It A 'Must-Own,' Says Bullish Analyst
September 25, 2024
From Benzinga
A Glimpse Into The Expert Outlook On Duolingo Through 11 Analysts
September 25, 2024
Tickers
DUOL
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.